• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-1MEF filed by PACS Group Inc.

    9/5/24 7:53:33 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care
    Get the next $PACS alert in real time by email
    S-1MEF 1 pacs-sx1mef952024.htm S-1MEF Document

    As filed with the Securities and Exchange Commission on September 5, 2024
    Registration No. 333-
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM S-1 
    REGISTRATION STATEMENT
    Under
    The Securities Act of 1933
    PACS GROUP, INC.
    (Exact name of registrant as specified in its charter)
    Delaware805192-3144268
    (State or other jurisdiction of
    incorporation or organization)
    (Primary Standard Industrial
    Classification Code Number)
    (I.R.S. Employer
    Identification No.)
    262 N. University Ave.
    Farmington, Utah 84025
    (801) 447-9829
    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
    Jason Murray
    Chief Executive Officer
    PACS Group, Inc.
    262 N. University Ave.
    Farmington, Utah 84025
    (801) 447-9829
    (Name, address, including zip code, and telephone number, including area code, of agent for service)
    Copies to:
    B. Shayne Kennedy
    J. Ross McAloon
    Latham & Watkins LLP
    650 Town Center Drive, 20th Floor
    Costa Mesa, CA 92626
    (714) 540-1235
    Benjamin K. Marsh
    Adam V. Johnson
    Goodwin Procter LLP
    The New York Times Building
    620 Eighth Avenue
    New York, NY 10018
    (212) 813-8800
    Approximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement is declared effective.
    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☐
    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ (File No. 333-281904) 
    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
    If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer☐Accelerated filer☐
    Non-accelerated filer☒Smaller reporting company☐
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
    The Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) promulgated under the Securities Act of 1933, as amended.



    EXPLANATORY NOTE AND INCORPORATION BY REFERENCE
    This Registration Statement on Form S-1 (this “Registration Statement”) is being filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, for the sole purpose of increasing the aggregate number of shares of common stock offered by PACS Group, Inc. (the “Registrant”) by 3,062,260 shares, 399,426 of which are subject to purchase upon exercise of the underwriters’ option to purchase additional shares of the Registrant’s common stock. The additional securities that are being registered for sale are in an amount and at a price that together represent no more than 20% of the maximum aggregate offering price set forth in the Filing Fee Table (Exhibit 107) filed as an exhibit to the Registration Statement on Form S-1 (File No. 333-281904) (the “Prior Registration Statement”). The information set forth in the Prior Registration Statement and all exhibits thereto are hereby incorporated by reference in this filing.
    The required opinion and consents are listed on an Exhibit Index attached hereto and filed herewith.



    Exhibit Index
    Exhibit
    Number
    Description of Exhibit
    5.1
    Opinion of Latham & Watkins LLP (incorporated by reference to Exhibit 5.1 filed with the Prior Registration Statement on September 3, 2024)
    23.1
    Consent of Ernst & Young LLP, independent registered public accounting firm
    23.2
    Consent of Latham & Watkins LLP (included in Exhibit 5.1)
    24.1
    Power of Attorney (included on the signature page of the Prior Registration Statement filed on September 3, 2024)
    107
    Filing Fee Table



    SIGNATURES
    Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Farmington, State of Utah, on this 5th day of September, 2024.
    PACS GROUP, INC.
    By:/s/ Jason Murray
    Jason Murray
    Chief Executive Officer
    Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities held on the dates indicated.
    SignatureTitleDate
    /s/ Jason Murray
    Director, Co-Founder, Chairman and Chief Executive Officer
    (Principal Executive Officer)
    September 5, 2024
    Jason Murray
    /s/ Derick Apt
    Chief Financial Officer
    (Principal Financial Officer)
    September 5, 2024
    Derick Apt
    /s/ Michelle Lewis
    Chief Accounting Officer
    (Principal Accounting Officer)
    September 5, 2024
    Michelle Lewis
    *Director, Co-Founder and Executive Vice ChairmanSeptember 5, 2024
    Mark Hancock
    *DirectorSeptember 5, 2024
    Jacqueline Millard
    *DirectorSeptember 5, 2024
    Taylor Leavitt
    *
    DirectorSeptember 5, 2024
    Evelyn Dilsaver
    *By:/s/ Derick Apt
    Derick Apt
    Attorney-in-fact

    Get the next $PACS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PACS

    DatePrice TargetRatingAnalyst
    12/17/2025$44.00Overweight
    Analyst
    12/17/2024$18.00Overweight → Neutral
    Analyst
    11/6/2024$40.00Overweight
    JP Morgan
    10/9/2024$50.00Buy
    UBS
    9/11/2024$45.00Buy
    Citigroup
    6/28/2024$35.00Outperform
    Macquarie
    More analyst ratings

    $PACS
    SEC Filings

    View All

    PACS Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - PACS Group, Inc. (0002001184) (Filer)

    12/23/25 4:02:39 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - PACS Group, Inc. (0002001184) (Filer)

    12/1/25 4:02:18 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form DEF 14A filed by PACS Group Inc.

    DEF 14A - PACS Group, Inc. (0002001184) (Filer)

    11/25/25 4:03:34 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dilsaver Evelyn S bought $499,997 worth of shares (16,724 units at $29.90), increasing direct ownership by 278% to 22,739 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    11/26/25 4:46:20 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PACS Group Announces the Acquisition of Three Post-Acute Operations and the Real Estate of Four Facilities

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and one in Idaho, representing a total of 230 beds. The facilities are located in the Kenai Peninsula region of Alaska and the Boise metropolitan area of Idaho. The Company acquired the real estate associated with the two Alaska facilities, while the Idaho facility will operate under a lease arrangement with a third-party landlord. In addition, PACS recently acquired the real estate for two existing skilled nursing operations: Sierra Valley Rehab Center in Porterville, Californ

    1/20/26 5:41:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group, Inc. to Present at Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2026, at 5:15 p.m., Pacific Time

    PACS Group, Inc. (NYSE:PACS) announced today that Jason Murray, Chairman and Chief Executive Officer, and Mark Hancock, Executive Vice President and Interim Chief Financial Officer, will present at the annual J.P. Morgan Healthcare Conference in San Francisco. The presentation audio will be webcast live on Tuesday, January 13, 2026, at 5:15 pm Pacific Time. To access the live webcast, please visit the Investor Relations section of PACS's website at https://ir.pacs.com or at https://ir.pacs.com/news-events/ir-calendar. An archived version of the webcast will be available for at least 30 days following the presentation. About PACS™ PACS Group, Inc. is a holding company investing in post-a

    1/12/26 4:15:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Expands Management Team, Adding New Chief Compliance Officer and Chief Human Resource Officer to Executive Leadership Team

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announces the appointments of Kelly Priegnitz as Chief Compliance Officer and Trent Bingham as Chief Human Resources Officer. Mr. Bingham joined PACS on Nov. 10, while Ms. Priegnitz began her role on Dec. 1. Ms. Priegnitz joins PACS after serving as Executive Vice President and Chief Legal and Compliance Officer of Pinnacle Treatment Centers since 2020. Prior to her service at Pinnacle Treatment Centers, Ms. Priegnitz held a variety of senior healthcare compliance leadership roles throughout her career, including Senior Vic

    12/8/25 4:12:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Lewis Michelle Renee covered exercise/tax liability with 3,348 shares, decreasing direct ownership by 0.89% to 374,870 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    1/20/26 4:59:36 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Chief Legal Officer & Sec. Mitchell John Todd covered exercise/tax liability with 9,541 shares, decreasing direct ownership by 1% to 868,150 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    1/20/26 4:58:47 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    President & COO Jergensen Joshua covered exercise/tax liability with 21,998 shares, decreasing direct ownership by 0.81% to 2,703,682 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    1/20/26 4:57:41 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on PACS Group with a new price target

    Analyst resumed coverage of PACS Group with a rating of Overweight and set a new price target of $44.00

    12/17/25 9:24:40 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group downgraded by Analyst with a new price target

    Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00

    12/17/24 8:16:05 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    JP Morgan resumed coverage on PACS Group with a new price target

    JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00

    11/6/24 6:27:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:49 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:15 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 11:37:42 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Financials

    Live finance-specific insights

    View All

    PACS Group Announces the Acquisition of Three Post-Acute Operations and the Real Estate of Four Facilities

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and one in Idaho, representing a total of 230 beds. The facilities are located in the Kenai Peninsula region of Alaska and the Boise metropolitan area of Idaho. The Company acquired the real estate associated with the two Alaska facilities, while the Idaho facility will operate under a lease arrangement with a third-party landlord. In addition, PACS recently acquired the real estate for two existing skilled nursing operations: Sierra Valley Rehab Center in Porterville, Californ

    1/20/26 5:41:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Announces Business Updates

    Entered into Amendment and Waiver to Existing Credit Agreement Acquires Operations and Real Estate of 160-Bed Skilled Nursing Facility in Nevada PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced several business updates that build on the Company's momentum and strong year-to-date operational and financial performance. "The amendment and waiver to our credit agreement and the latest addition to our growing portfolio demonstrate how our team continues to execute on our strategy and position our business for continued growth," said Jason Murray, PACS's Chief Execu

    12/1/25 4:15:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care